Friday, July 15, 2016

Valeant psoriasis drug safety challenging to assess -FDA Staff

July 15 (Reuters) - Valeant Pharmaceuticals International

Inc's experimental drug to treat the skin disorder

psoriasis carries several potential risks that are challenging

to assess due to limited...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)